Synpromics’ products comprise, or are based on, patentable synthetic promoters that are designed to regulate genes in any cell type or any environmental condition.

Synpromics' products vastly improve upon the natural promoters on which the entire biotech industry currently relies to regulate genes. The company's technology allows it to leverage a cell's transcriptome, or gene expression profile, to design and construct synthetic promoters that are only active in a specific cell type that is subject to a particular condition of interest.

This has not been possible until now and consequently there is enormous potential for Synpromics to use its technology to transform the entire Biotech sector. The company is currently active in a number of diverse fields, including: Cell & Gene Therapy, Biologics Bioprocessing and Industrial Biotechnology. Additionally, we are open to applying our technology to new disciplines and welcome enquiries from organisations wishing to improve gene expression in their model system.

Synthetic Promoter Design

Proprietary Promoter Design Process

Synpromics is developing a strategic portfolio of valuable synthetic promoters for specific application across its target markets, such as gene therapy, bio-manufacturing and industrial biotechnology.

Read more



Synpromics has developed PromPT, its multi-dimensional bioinformatics engine and DNA assembly platform.

Read more